Abstract
Separation and retention of both polar and nonpolar compounds by the same stationary phase can be a useful approach for analyses of complex samples. Biological samples encompass a broad range of polarities and varied chemical properties. A gradient elution run with acetonitrile-water as the mobile phase was used for the separation of polar and non polar compounds from Aphanothece halophytica using ODS C18 column with photo diode array detection. The various fractions collected were identified through Electrospray ionisation-mass spectrometry (ESI-MS) and Nuclear Magnetic Resonance (NMR) analyses. The High Performance Liquid Chromatography (HPLC) method provided good baseline separation of all the compounds in 15 min without the need for sample derivatization. Retrospective review of ESI-MS and NMR data identified the major compounds as nostocyclamide, trimethylglycine, phosphatidyl glycerol.
Keywords: Aphanothece halophytica, bioactive compounds, HPLC, ESI-MS, NMR, nostocyclamide.
The Natural Products Journal
Title:Separation of Bioactive Metabolites from Aphanothece Halophytica Through HPLC and Characterization of the Analytes Through ESI-MS and NMR
Volume: 3 Issue: 2
Author(s): Rashi Vishwakarma and Ashwani Kumar Rai
Affiliation:
Keywords: Aphanothece halophytica, bioactive compounds, HPLC, ESI-MS, NMR, nostocyclamide.
Abstract: Separation and retention of both polar and nonpolar compounds by the same stationary phase can be a useful approach for analyses of complex samples. Biological samples encompass a broad range of polarities and varied chemical properties. A gradient elution run with acetonitrile-water as the mobile phase was used for the separation of polar and non polar compounds from Aphanothece halophytica using ODS C18 column with photo diode array detection. The various fractions collected were identified through Electrospray ionisation-mass spectrometry (ESI-MS) and Nuclear Magnetic Resonance (NMR) analyses. The High Performance Liquid Chromatography (HPLC) method provided good baseline separation of all the compounds in 15 min without the need for sample derivatization. Retrospective review of ESI-MS and NMR data identified the major compounds as nostocyclamide, trimethylglycine, phosphatidyl glycerol.
Export Options
About this article
Cite this article as:
Vishwakarma Rashi and Rai Ashwani Kumar, Separation of Bioactive Metabolites from Aphanothece Halophytica Through HPLC and Characterization of the Analytes Through ESI-MS and NMR, The Natural Products Journal 2013; 3 (2) . https://dx.doi.org/10.2174/2210315511303020010
DOI https://dx.doi.org/10.2174/2210315511303020010 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer
Current Medical Imaging Applications of Nanosystems to Anticancer Drug Therapy (Part II. Dendrimers, Micelles, Lipid-based Nanosystems)
Recent Patents on Anti-Cancer Drug Discovery Role of Immunostimulatory Molecules in Poultry Vaccines
Recent Patents on Biotechnology Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Current Medicinal Chemistry Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets Towards Improved Therapies Using Nanopharmaceuticals: Recent Patents on Pharmaceutical Nanoformulations
Recent Patents on Food, Nutrition & Agriculture Application of Phage Display Technology to Cancer Research
Current Pharmaceutical Biotechnology Nerve Growth Factor Receptors and Signaling in Breast Cancer
Current Cancer Drug Targets Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer
Anti-Cancer Agents in Medicinal Chemistry Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins
Current Cancer Drug Targets Adipocytes Derived from Human Bone Marrow Mesenchymal Stem Cells Exert Inhibitory Effects on Osteoblastogenesis
Current Molecular Medicine Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs Cell Cycle Dependent Regulation of Intracellular Calcium Concentration in Vascular Smooth Muscle Cells: A Potential Target for Drug Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Targeted Therapy for Brain Tumours: Role of PARP Inhibitors
Current Cancer Drug Targets Stem Cell Guardians – Old and New Perspectives in LSC Biology
Current Drug Targets The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Current Drug Targets